跳至主要内容
临床试验/NCT01919385
NCT01919385已完成1 期

Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting

Animas Corporation2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Evaluate the performance of the System while the subject is under close medical supervision in the Clinical Research Center (CRC) setting

研究概览

简要总结

This study will be conducted in a Clinical Research Center (CRC) setting and recruiting type 1 diabetes that are currently using an insulin pump.

详细描述

This study is a non-randomized, uncontrolled feasibility study that looks to enroll people with type 1 diabetes who are currently using an insulin pump. During the subject's participation, the study staff will closely monitor the study subject in a clinical research center environment for approximately 30 hours, while controller algorithm determined insulin doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21-65 years
  • Type 1 diabetes mellitus for at least one year
  • Currently using an insulin infusion pump for at least the past 6 months

排除标准

  • Pregnancy
  • History of Diabetic Ketoacidosis (DKA) in the past six months
  • History of severe hypoglycemia (Seizure, unconsciousness) in the past 6 months

结局指标

主要结局

Evaluate the performance of the System while the subject is under close medical supervision in the Clinical Research Center (CRC) setting

时间窗: 1 week after subject is enrolled in the study

Evaluating the ability of the system to predict a fall or rise in glucose values below or above a low glucose threshold, and take the corresponding appropriate action of reducing or suspending insulin delivery in order to keep the subject's glucose above this threshold, or resuming insulin delivery at the current basal rate upon the increase of glucose above this threshold. Ability of the system to issue timely and accurate warnings.

次要结局

  • Capturing the number of Adverse Events as a measure of assessing subject safety(1 week after subject is enrolled in the study)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验